InFLAMES Corporate Corner – The Journey of Turning Science into Business
Welcome to the InFLAMES Research Flagship’s Corporate Corner titled The Journey of Turning Science into Business on Friday October 6th, 2023. The event will be held at the Old Academy Building, Rothoviuksenkatu 2, Turku.
How do scientists recognise the opportunity to transform medical research into practical healthcare solutions, life-saving treatments and pioneering technologies? InFLAMES Corporate Corner presents diverse stories and perspectives on this topic, shedding light on what it takes for scientists to unravel medical mysteries and translate them into practical enhancements for our lives.
Our line-up of esteemed speakers, including representatives from InFLAMES, Biovian, Faron Pharmaceuticals, Innovestor, Almaral, The Finnish Medicines Agency Fimea, National Drug Development Centre, THESTRA and Genomill, will provide insights into this transformative journey.
All interested parties are welcome. SIGN UP HERE! (Registration closed on September 27th. However, you can still join the waiting list. If seats become available, we will notify you promptly.)
Confirmed speakers:
CEO Markku Jalkanen, Faron Pharmaceuticals
CEO Antti Nieminen, Biovian
Milla Koistinaho, Innovestor
Partner Pekka Hilden, Almaral
Coordinating Senior Medical Officer Outi Mäki-Ikola, The Finnish Medicines Agency Fimea
CTO Manu Tamminen, Genomill
Professor Jukka Westermarck, University of Turku / Co-founder of THESTRA
Chief Specialist Tarja Enala, Ministry of Economic Affairs and Employment of Finland
Dean Pekka Hänninen, Faculty of Medicine, University of Turku
Host of the event is Director of InFLAMES Flagship Academician Sirpa Jalkanen.
We start with lunch at 11:30 and after the official programme from 16:00 you are welcome to the networking afterparty. The event is part of a week-long celebration of the 80th Anniversary of the Faculty of Medicine at the University of Turku taking place October 2nd to 6th, 2023.
Programme
11:30-12:15 Lunch (can also be enjoyed during presentations)
12:15-13:10
Chair: Academician Sirpa Jalkanen, InFLAMES Flagship, University of Turku
Opening words, InFLAMES Director Sirpa Jalkanen
The courage of turning science into a business,
Dean Pekka Hänninen, Faculty of Medicine, University of Turku, Finland
From basic science to investing and founding companies
CEO Markku Jalkanen, Faron Pharmaceuticals
13:10-13:30 Coffee Break
13:30-14:40
The development story of Biovian from management buy-out to globally operating, successful CMO
CEO Antti Nieminen, Biovian
From basic research to drug development to regulation of medicines
Coordinating Senior Medical Officer Outi Mäki-Ikola, Finnish Medicines Agency
14:40-14:50 Break
14:50-16:25
Chair: Head of Business Development Anne Marjamäki, University of Turku
How a scientist turned into an entrepreneur and an investor: Unmasking investor perspectives
Founding Partner Milla Koistinaho, Innovestor
Almaral – Investment strategy and evaluation of companies
Partner Pekka Hilden, Almaral
Startup Story: Genomill
CTO Manu Tamminen, Genomill
Startup Story: THESTRA
Professor Jukka Westermarck, University of Turku / Co-founder of THESTRA
Finnish Drug Discovery Center
Chief Specialist Tarja Enala, Ministry of Economic Affairs and Employment of Finland
Closing words, Sirpa Jalkanen
16:25-19:00 Networking over drinks and refreshments (The Old Academy Building, second floor)
